Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes

Abstract Obstructive hypertrophic cardiomyopathy (oHCM) is a subtype of HCM characterized by left ventricular outflow tract obstruction resulting from cardiac muscle hypertrophy and anatomic alterations in the mitral valve and apparatus. Mavacamten, a cardiac myosin inhibitor metabolized primarily b...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xiaojie Wu, Nanye Chen, Peiwen Hsu, Jing Sun, Wenting Li, Qi Wang, Merali Samira, Qiong Wei, Jicheng Yu, Guoying Cao, Haijing Yang, Lili Wang, Jingjing Wang, Yi Jin, Wei Liu, Jufang Wu, Jinjie He, Cheng Lyu, Jing Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2024-07-01
Series:	Clinical and Translational Science
Acceso en liña:	https://doi.org/10.1111/cts.13877
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!